-
Aegis Sciences Corporation announces it has been awarded $6.6 million NIH grant to rapidly expand COVID-19 Test Capacity
Capacity for 60,000 tests a day expected by September 30 with most results available within 24 hours Nashville, Tennessee (September 2, 2020) – Aegis…
Capacity for 60,000 tests a day expected by September 30 with most results available within 24 hours Nashville, Tennessee (September 2, 2020) – Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and consulting services to providers has been selected to participate in the National Institutes of Health Rapid Acceleration of Diagnostics…
-
Aegis Sciences Corporation and QURE Announce Groundbreaking Results from InterACT Rx™ Study Demonstrating Objective Identification of Drug-drug Interactions Linked to Improved Patient Outcomes
Physicians using InterACT Rx were 3x more likely to recognize and treat patients impacted by DDIs resulting in improved patient outcomes. SAN FRANCISCO…
Physicians using InterACT Rx were 3x more likely to recognize and treat patients impacted by DDIs resulting in improved patient outcomes. SAN FRANCISCO and NASHVILLE, Tenn., Sept. 15, 2021 - The results of the prospective randomized DECART-2 study were released on July 15, 2021 in the journal, Diagnostics. The research, conducted among 331 patients of primary care physicians (PCP), showed that InterACT…
-
Aegis now a Blue Cross Blue Shield of Texas participating provider
NASHVILLE, TN (September 1, 2020) - Aegis Sciences Corporation is pleased to announce that effective September 1, 2020 we will be a participating laboratory…
NASHVILLE, TN (September 1, 2020) - Aegis Sciences Corporation is pleased to announce that effective September 1, 2020 we will be a participating laboratory provider with Blue Cross and Blue Shield in Texas for Commercial, Managed Medicare and Managed Medicaid. Our product participation with Blue Cross Blue Shield Texas will allow referring physicians to utilize Aegis’ laboratory services and members…
-
HHS Announces collaboration with Aegis Sciences Corporation to ramp high quality COVID-19 RT-PCR testing with fast results
Today, the U.S. Department of Health and Human Services announced combined investments of $6.5 million in two commercial diagnostic laboratories to expand…
Today, the U.S. Department of Health and Human Services announced combined investments of $6.5 million in two commercial diagnostic laboratories to expand capacity to conduct up to 4 million additional SARS-CoV-2 per month. SARS-CoV-2 is the virus that causes COVID-19.
-
Aegis Sciences provides & expands COVID-19 testing ‘smartly’ – patient-centric, medically-focused
NASHVILLE, TN (WSMV) - The number of people getting testing for coronavirus nationwide is growing rapidly, which is causing the biggest laboratories in…
NASHVILLE, TN (WSMV) - The number of people getting testing for coronavirus nationwide is growing rapidly, which is causing the biggest laboratories in Tennessee to expand to fit the growing needs.
-
Aegis Sciences Corporation Testing for Coronavirus Disease 2019 (COVID-19) Now Authorized to Report in all 50 states
NASHVILLE, Tenn., (June 09, 2020) -- Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance…
NASHVILLE, Tenn., (June 09, 2020) -- Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and consulting services to providers, announced that it is now registered and approved to provide public health reporting of COVID-19 diagnostic test results to State Departments of Health in all 50 U.S states. Since making its COVID-19 diagnostic…
-
Aegis Sciences Corporation Announces Oral Fluid Testing Enhancement
Nashville, Tennessee (June 8, 2020) – Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance…
Nashville, Tennessee (June 8, 2020) – Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and consulting services to providers, announced expanded oral fluid testing options. Testing for over 100 medications and illicit drugs is now available in oral fluid. The enhancement includes additions of antipsychotics, antidepressants,…
-
Aegis Sciences Corporation expands InterACT Rx™ Testing Capabilities
Nashville, Tennessee (May 6, 2020) – Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance…
Nashville, Tennessee (May 6, 2020) – Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and consulting services to providers, implemented an expanded InterACT Rx™ test offering on April 1, 2020. Testing will now include over 180 total analytes, and more than 130 drugs or substances. In order to better serve healthcare providers,…
-
Aegis Sciences Corporation Doubles Capacity for Coronavirus Disease 2019 (COVID-19) Testing
Capacity for 7,000 tests a day begins May 4 in response to community need Nashville, Tennessee (April 27, 2020) – Aegis Sciences Corporation, a leading…
Capacity for 7,000 tests a day begins May 4 in response to community need Nashville, Tennessee (April 27, 2020) – Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and consulting services to providers, announced expanded capacity to incrementally ramp up to 7,000 tests per day since first making COVID-19 testing available on…
-
Aegis Sciences Corporation gears up for COVID-19 testing
April 16, 2020 - Aegis Sciences was featured on WSMV News4 Nashville - view clip For more information and details about how you can access Aegis’s COVID-19…
April 16, 2020 - Aegis Sciences was featured on WSMV News4 Nashville - view clip For more information and details about how you can access Aegis’s COVID-19 testing service, please visit www.aegislabs.com, email COVIDtest@aegislabs.com or call 615-99COVID (615.992.6843).